![Boston_H_color[33632]_edited.png](https://static.wixstatic.com/media/e60c5c_0b72738a80554196840094a8e387c5ed~mv2.png/v1/fill/w_338,h_77,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/Boston_H_color%5B33632%5D_edited.png)
Primary HLH and Gamifant Educational Program
May 17, 6:00 PM – 7:00 PM EDT
Boston, 900 Boylston St, Boston, MA 02115, USA
Join Sobi and other healthcare professionals for an in-person presentation featuring an overview of primary hemophagocytic lymphohistiocytosis (HLH) diagnosis and treatment with Gamifant. The session will include an in-depth look at Gamifant as an interferon gamma–blocking antibody treatment option and a Q&A segment for additional information.